INIS
antioxidants
32%
barriers
20%
biological markers
30%
cardiovascular diseases
23%
comets
15%
concentration
20%
dna repair
15%
humans
32%
hypoxia
90%
in vitro
18%
inflammation
21%
intake
17%
levels
59%
lysine
30%
maturation
15%
mice
21%
mitochondria
50%
optimization
15%
oxidation
42%
oxygen
17%
patients
15%
placenta
99%
plasma
46%
pregnancy
45%
quercetin
26%
risks
24%
tissues
21%
toxicity
15%
vasoconstriction
15%
veins
15%
Keyphrases
Base Excision Repair
15%
BeWo Cells
16%
Cardiovascular Effects
15%
Chorioamnionitis
15%
Clinical Trials
15%
Comet Assay
15%
Complicated Pregnancy
18%
DNA Repair Assay
15%
Healthy Elderly Subjects
15%
Human Umbilical Vein Endothelial Cells (HUVECs)
15%
Hydrogen Peroxide
15%
Hypoxia
33%
Methylglyoxal
60%
Mitochondrial Abnormalities
30%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
15%
Oxidative Stress
25%
Placenta
71%
Placental Hypoxia
55%
Placental Tissue
18%
Preeclampsia
100%
Preeclamptic
32%
Quercetin
18%
Rutin
15%
Vascular Complications
20%
Vascular Contraction
16%
Vascular Endothelial
15%
Vascular Function
18%
Vascular Morphology
15%
Villous Maturation
15%
Western World
15%
Medicine and Dentistry
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
13%
6 N Carboxymethyllysine
8%
Advanced Glycation End-Product
6%
Antioxidant
13%
Arteriole
15%
Artery
6%
Biological Marker
30%
Cell Viability
7%
Chorioamnionitis
15%
Disease
12%
Endothelial Cell
7%
Glyoxalase
7%
Human Umbilical Vein Endothelial Cell
15%
Hydrogen Peroxide
15%
Hypoxia
72%
Maturation
15%
Methylglyoxal
45%
Mitochondrial Toxicity
15%
Muscle Contractility
15%
Myography
10%
Oxidative Stress
32%
Placenta
54%
Pre-Eclampsia
88%
Quercetin
19%
Reactive Oxygen Species
11%
Rutin
15%
Thromboxane
6%
Transcription Factor Nrf2
15%
Vascularity
6%
Vasoconstriction
12%
